...
首页> 外文期刊>Saudi Pharmaceutical Journal >Pharmacy Malpractice: The rate and prevalence of dispensing high-risk prescription-only medications at community pharmacies in Saudi Arabia
【24h】

Pharmacy Malpractice: The rate and prevalence of dispensing high-risk prescription-only medications at community pharmacies in Saudi Arabia

机译:药业不当行为:在沙特阿拉伯的社区药房中分发高风险处方药的比例和普遍性

获取原文
           

摘要

Objective: To assess the compliance of community pharmacies with the regulations that prohibit the dispensing of prescription-only medications in the absence of a physician prescription in Saudi Arabia. Method: A cross-sectional study was conducted in the period between October 2014 and January 2015. A list of 10 prescription-only medications were selected to be studied. 150 community pharmacies were visited across 6 major regions in Saudi Arabia to assess the prevalence of non-compliance among community pharmacies. Pharmacies were selected in random and researchers (disguised as patients) requested to purchase prescription-only medications in the absence of a prescription. Not all medications were purchased at once. Data were recorded per pharmacy, where pharmacies that approved dispense of the selected drug were scored as non-compliant and the pharmacies that rejected dispense of the selected drug were scored as compliant. Compliance rate was calculated per region per drug. Pharmacies based in governmental hospitals were visited in parallel. A total of 20 were visited. Data and statistical analysis were performed using Statistical Analyses Software (SAS 9.3). Results: A total of 150 pharmacies were visited over a period of 3 months. On average, the percent approved dispense of prescription-only drugs across 6 regions in Saudi Arabia is 63% and the percent rejected dispense is 37% representing a significant non-compliance rate regarding the selected list of medications in this study. The frequency of dispense per medication across 6 major regions in Saudi Arabia is as follows: Isosorbide dinitrate (86%), Enoxaparin (82%), nitroglycerin (74%), Propranolol (73%), Verapamil (70%), Warfarin (65%), Methyldopa (64%), Ciprofloxacin (57%) and Codeine (4%). Conclusions: Non-compliance of community pharmacies with the law of pharmaceutical practice is at an alarming rate in the Kingdom of Saudi Arabia and authoritative figures must intervene to impede and combat such activities.
机译:目的:评估沙特阿拉伯社区药房对禁止在没有医生处方的情况下分发仅处方药的法规的遵守情况。方法:在2014年10月至2015年1月期间进行了一项横断面研究。选择了10种仅处方药的清单进行研究。在沙特阿拉伯的6个主要地区访问了150家社区药房,以评估社区药房中违规行为的发生率。随机选择药房,研究人员(伪装成患者)要求在没有处方的情况下购买仅处方药。并非一次性购买所有药物。每个药房记录数据,其中批准分配所选药物的药店被评为不合规,拒绝分配所选药物的药店被记为合规。计算每种药物每个区域的依从率。同时访问了政府医院的药房。总共访问了20个。使用统计分析软件(SAS 9.3)进行数据和统计分析。结果:在3个月的时间内,总共访问了150家药房。平均而言,在沙特阿拉伯的6个地区中,仅处方药的批准配药百分比为63%,拒绝配药的百分比为37%,这表明本研究中所选药物清单的违规率很高。在沙特阿拉伯的6个主要地区,每种药物的分配频率如下:硝酸异山梨酯(86%),依诺肝素(82%),硝酸甘油(74%),普萘洛尔(73%),维拉帕米(70%),华法林( 65%),甲基多巴(64%),环丙沙星(57%)和可待因(4%)。结论:沙特阿拉伯王国社区药房不遵守药品经营法的情况令人震惊,必须要有权威人士干预才能阻止和打击此类活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号